"Expanding knowledge and access
to emergency contraception"
"Expanding knowledge and access to emergency contraception in Europe"
These posts appear under the ‘Latest News’ heading.
July 2026. A new YouGov survey highlights persistent barriers to timely access to emergency contraception (EC) in the United Kingdom (UK), particularly outside regular pharmacy opening hours. Many respondents considered obtaining EC on a Sunday or after 10 p.m. to be difficult. Despite important progress in improving access to EC in the UK, the survey…
June 2026. In the United Kingdom, The College of Sexual & Reproductive Healthcare (CoSRH) – formerly FSRH-, has updated its Clinical Guideline on Emergency Contraception. One change in the latest amendments (April 2026) concerns breastfeeding after use of ulipristal acetate (UPA) emergency contraception. Following a review of the available evidence, the College now advises that…
June 2026. Poland’s Ministry of Health has announced plans to extend the pilot programme that allows pharmacists to issue prescriptions for emergency contraception (EC) pills directly in participating pharmacies. The programme, which began on 1 May 2024, was originally scheduled to run for 25 months, until June 2026. Following positive uptake, the Ministry has indicated…
June 2026. The Contraceptive Technology Innovation (CTI) Tracker is a free online resource that follows new contraceptive methods and technologies under development around the world. It includes products in the early stages of research, those undergoing clinical testing and products with single-country regulatory approval. The Tracker covers both ongoing and discontinued projects, providing a very…
May 2026. The next FIAPAC Conference will take place in Barcelona in October 2-3, 2026. FIAPAC is Europe’s leading forum bringing together healthcare professionals, researchers, and activists working in the fields of contraception and abortion. This year’s conference will explore the concept of “contragestion”: a potential fertility control intervention situated between contraception and abortion; a…
May 2026. On the occasion of the International Day of Action for Women’s Health, the European Society of Contraception and Reproductive Health launches its new Position Paper on Sexual and Reproductive Health and Rights (Belgrade, 2026), reaffirming its commitment to defending sexual and reproductive health and rights (SRHR) as fundamental human rights, and to evidence-based…
May 2026. The Hungarian women’s rights organisation PATENT Association is running a campaign calling for the reclassification of emergency contraceptive pills (ECPs) to make them available without prescription in Hungary. The campaign, Magyarországon is legyen recept nélkül kapható az esemény utáni tabletta! (or “Make emergency contraception available over the counter in Hungary”), highlights the unnecessary…
May 2026. The Swiss House of Representatives has voted in favor of easing access to emergency contraceptive pills (ECPs) by removing the mandatory pharmacist counselling requirement . The motion, adopted on 30 April would make access to ECPs less restrictive and bring Switzerland closer to practices in most other European countries. The proposal will now…
April 2026. We’re pleased to share that ECEC will be attending the European Society of Contraception and Reproductive Health (ESCRH) Congress in Belgrade on May 6-9. Join us for a dedicated session on Emergency Contraception: Thursday, 7 May 2026 Block 4 Emergency Contraception Chairs: Kristina Gemzell (Sweden) & Aleksandar Jurisic (Serbia) We look forward to…
April 2026 — A new levonorgestrel-based emergency contraceptive (EC) pill, Lesoeru 72, has been approved and launched in Japan, becoming the second brand available without a prescription in the country. According to Fuji Pharma Co., Ltd., approval was granted on 10 February 2026, with distribution starting in March. Lesoeru 72 is classified as a pharmaceutical…
April 2026 — A ulipristal acetate (UPA)-based emergency contraceptive (EC) pill is now available in Argentina. Since March 2026, Efectiva 30, manufactured by Laboratorios CASASCO, has been distributed in pharmacies nationwide. The product is available by prescription only and is expected to retail at approximately USD 12, with lower prices anticipated through union-run health insurance…
April 2026. The latest State of Self-Care Report 2025 highlights growing interest in new, user-controlled contraceptive options, including pericoital (on-demand) pills. Two case studies from Malawi, Kenya, and Uganda provide valuable insights into how women and adolescent girls perceive these methods and the potential role they could play in expanding contraceptive choice. Summary of findings:…
Menú